Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 25027324)

1.

Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.

Hathout Y, Marathi RL, Rayavarapu S, Zhang A, Brown KJ, Seol H, Gordish-Dressman H, Cirak S, Bello L, Nagaraju K, Partridge T, Hoffman EP, Takeda S, Mah JK, Henricson E, McDonald C.

Hum Mol Genet. 2014 Dec 15;23(24):6458-69. doi: 10.1093/hmg/ddu366. Epub 2014 Jul 15.

PMID:
25027324
2.

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.

Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS.

Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.

PMID:
24443351
3.

Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.

Ito K, Kimura S, Ozasa S, Matsukura M, Ikezawa M, Yoshioka K, Ueno H, Suzuki M, Araki K, Yamamura K, Miwa T, Dickson G, Thomas GD, Miike T.

Hum Mol Genet. 2006 Jul 15;15(14):2266-75. Epub 2006 Jun 15.

4.

Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.

Ahmad A, Brinson M, Hodges BL, Chamberlain JS, Amalfitano A.

Hum Mol Genet. 2000 Oct 12;9(17):2507-15.

5.

Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.

Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ.

J Cell Biol. 2001 Mar 19;152(6):1207-18.

6.

Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy.

Rouillon J, Zocevic A, Leger T, Garcia C, Camadro JM, Udd B, Wong B, Servais L, Voit T, Svinartchouk F.

Neuromuscul Disord. 2014 Jul;24(7):563-73. doi: 10.1016/j.nmd.2014.03.012. Epub 2014 Apr 13.

PMID:
24813925
7.

Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K.

Mol Cell Proteomics. 2013 May;12(5):1061-73. doi: 10.1074/mcp.M112.023127. Epub 2013 Jan 7.

8.

Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?

Niebrój-Dobosz I, Fidziańska A, Glinka Z, Hausmanowa-Petrusewicz I.

Folia Neuropathol. 2002;40(3):143-50.

PMID:
12572920
9.

Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.

van Putten M, Hulsker M, Young C, Nadarajah VD, Heemskerk H, van der Weerd L, 't Hoen PA, van Ommen GJ, Aartsma-Rus AM.

FASEB J. 2013 Jun;27(6):2484-95. doi: 10.1096/fj.12-224170. Epub 2013 Mar 4.

10.

Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.

Krämer R, Lochmüller H, Abicht A, Rüdel R, Brinkmeier H.

Neuromuscul Disord. 1998 Dec;8(8):542-50.

PMID:
10093060
11.

Increased neointimal thickening in dystrophin-deficient mdx mice.

Rauch U, Shami A, Zhang F, Carmignac V, Durbeej M, Hultgårdh-Nilsson A.

PLoS One. 2012;7(1):e29904. doi: 10.1371/journal.pone.0029904. Epub 2012 Jan 4.

12.

Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se.

Endesfelder S, Krahn A, Kreuzer KA, Lass U, Schmidt CA, Jahrmarkt C, von Moers A, Speer A.

J Mol Med (Berl). 2000;78(10):569-74.

PMID:
11199330
13.

A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.

Chandrasekharan K, Yoon JH, Xu Y, deVries S, Camboni M, Janssen PM, Varki A, Martin PT.

Sci Transl Med. 2010 Jul 28;2(42):42ra54. doi: 10.1126/scitranslmed.3000692.

14.

[Study on the gene knockout model mice of Duchenne muscular dystrophy].

Chen S, Zhang C, Liu X, Gao L, Zhang W, Huang W, Lu X, Wang Z.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Apr;34(2):210-3. Chinese.

PMID:
12947691
15.

Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.

van Putten M, Kumar D, Hulsker M, Hoogaars WM, Plomp JJ, van Opstal A, van Iterson M, Admiraal P, van Ommen GJ, 't Hoen PA, Aartsma-Rus A.

Neuromuscul Disord. 2012 May;22(5):406-17. doi: 10.1016/j.nmd.2011.10.011. Epub 2012 Jan 27.

16.

Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling.

Turk R, Sterrenburg E, de Meijer EJ, van Ommen GJ, den Dunnen JT, 't Hoen PA.

BMC Genomics. 2005 Jul 13;6:98.

17.

Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy.

De Oliveira Moreira D, Pereira JA, Taniguti AP, Matsumura CY, Ramos LA, Areas MA, Neto HS, Marques MJ.

Muscle Nerve. 2013 Dec;48(6):911-9. doi: 10.1002/mus.23858. Epub 2013 Sep 11.

PMID:
23536447
18.

Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.

Porter JD, Merriam AP, Leahy P, Gong B, Feuerman J, Cheng G, Khanna S.

Hum Mol Genet. 2004 Feb 1;13(3):257-69. Epub 2003 Dec 17.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk